New hope for leukemia patients: experimental drug YK012 enters human trials
NCT ID NCT06580301
First seen Feb 06, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study tests a new drug, YK012, in 46 people with B-cell acute lymphoblastic leukemia (B-ALL), a type of blood cancer. The main goals are to check the drug's safety, find the best dose, and see if it can shrink or control the cancer. Participants must have CD19-positive B-ALL and be well enough for treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Zhongshan Hospital of Dalian University
RECRUITINGDalian, Liaoning, 116001, China
Contact
Contact
-
Guangdong Provincial People's Hospital
RECRUITINGGuangzhou, Guangdong, 510080, China
Contact
-
Henan Provincial People's Hospital
RECRUITINGZhengzhou, Henan, 450003, China
Contact
-
Shengjing Hospital of China Medical University
RECRUITINGShenyang, Liaoning, 110000, China
Contact
-
Sun Yat-sen Memorial Hospital
RECRUITINGGuangzhou, Guangdong, 510000, China
Contact
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510000, China
Contact
-
The Affiliated Hospital of Guizhou Medical University
RECRUITINGGuiyang, Guizhou, 550004, China
Contact
-
The Affiliated Hospital of Xuzhou Medical University
RECRUITINGXuzhou, Jiangsu, 221000, China
Contact
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, 330006, China
Contact
-
The First Affiliated Hospital, Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310003, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Hospital of Jilin University
RECRUITINGChangchun, Jilin, 130021, China
Contact
-
The Second Affiliated Hospital of Kunming Medical University
RECRUITINGKunming, Yunnan, 650033, China
Contact
Conditions
Explore the condition pages connected to this study.